Mayo Clinic’s new CEO pick puts AI experience in the top job

Mayo Clinic HQ representing new CEO appointment

Mayo Clinic has chosen the physician who leads its generative AI work as its next CEO. The Mayo Clinic Board of Trustees announced on Nov. 13 that it had elected Dr. Matthew Callstrom to succeed Dr. Gianrico Farrugia as president and CEO.

Callstrom, an interventional radiologist and physician-scientist, takes the top job on Jan. 1, 2027. Farrugia, who has led Mayo since 2019 and said earlier this year that he would step down, stays in post through Dec. 31 and will work with Callstrom on the handover.

In one sense, the appointment keeps a long Mayo tradition intact. The new CEO is again a physician promoted from inside the organization. What stands out is the portfolio he brings with him. Callstrom currently serves as medical director for Mayo Clinic Strategy and its AI program, so the institution’s long-range plan and its AI work already sit on his desk.

For health system leaders, that combination says a lot about where the top job is heading.

Mayo’s new CEO arrives from strategy and AI, not only the clinic

Callstrom has spent nearly 25 years at Mayo Clinic. He built his clinical career in image-guided cancer treatment, where interventional radiologists use live imaging to guide minimally invasive procedures instead of open surgery. He has more than 200 publications and patents, has served as president of the Society of Interventional Oncology, and previously chaired the Department of Radiology at Mayo Clinic in Rochester, Minnesota.

His more recent roles moved him toward enterprise leadership. He served as Mayo’s interim chief strategy officer and now directs both its Strategy Department and its Generative Artificial Intelligence program, which works on bringing AI into medicine, including earlier detection of disease. He also sits on Mayo’s Board of Governors and Board of Trustees.

The board’s chair, Richard K. Davis, pointed to that mix of clinical and organizational experience. “Dr. Callstrom is an accomplished physician-scientist and enterprise leader who brings nearly 25 years of experience at Mayo Clinic and a deep commitment to our values and mission,” he said.

Callstrom said he was “deeply honored to have the opportunity to lead Mayo Clinic in this moment.” He framed his goal as turning discovery and new technology into better care for patients, faster.

That framing matters. It places AI inside Mayo’s existing mission of research and patient care, rather than presenting it as a separate digital project.

Callstrom inherits a platform strategy built over 8 years

Farrugia’s tenure sets the context for the handover. During his time as CEO, Mayo set out a long-term strategy and launched Mayo Clinic Platform, which the organization describes as an AI-enabled platform for transforming care. Mayo has also taken that work into partnerships, including a plan with Microsoft to build AI models designed for healthcare.

Choosing the head of the AI program to follow him points to continuity rather than a reset. As medical director of strategy, Callstrom has worked inside the plan he now inherits. Farrugia made a similar point, saying his successor “knows Mayo Clinic deeply, understands where healthcare is headed.”

For other health systems, the signal is clear. AI experience is becoming a credential for the CEO’s office, not only for a chief digital or chief AI officer reporting several levels down.

That changes what a board looks for when it plans succession. Clinical standing, operational experience, and financial discipline remain the core requirements. Mayo’s choice suggests that a record of putting AI to work in clinical settings now belongs on the same list.

It also raises expectations. A CEO who has run an AI program will be judged on whether that work reaches patients at scale, not on pilots and announcements.

Turning AI work into everyday care is the harder test

Callstrom’s background in an image-based specialty gives him a clinician’s view of how AI tools fit into daily practice.

Running the whole organization is a different task. Moving AI from a research program into routine care across a large system involves clinician trust, data governance, workflow changes, and questions about who is accountable when an algorithm informs a decision. Those issues sit with the CEO as much as with any technology team.

Callstrom will also lead an organization whose identity rests on its clinicians and researchers. Keeping physicians on board as AI tools reach more of their daily work may prove as important as any technical decision.

The appointment answers one question about Mayo’s direction. Several others stay open. How quickly will Mayo move its AI work from pilots into everyday practice under a CEO who has led that work? Who will take over the strategy and AI roles Callstrom leaves behind? And will other large systems now look harder at AI leaders when they plan their own successions?

Source:
Mayo Clinic News Network
MPR News

Media

© 2026 American Healthcare Leader. All rights reserved.